Title : In vivo pharmacology and toxicology evaluation of polyethylene glycol-conjugated interferon beta-1a.

Pub. Date : 2011 Sep

PMID : 21690216






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 A 20-kDa polyethylene glycol (PEG)-conjugated IFN beta-1a (PEG-IFN beta-1a) is being developed to decrease the frequency of administration and improve patient convenience and compliance. Polyethylene Glycols interferon beta 1 Homo sapiens
2 A 20-kDa polyethylene glycol (PEG)-conjugated IFN beta-1a (PEG-IFN beta-1a) is being developed to decrease the frequency of administration and improve patient convenience and compliance. Polyethylene Glycols interferon beta 1 Homo sapiens
3 A 20-kDa polyethylene glycol (PEG)-conjugated IFN beta-1a (PEG-IFN beta-1a) is being developed to decrease the frequency of administration and improve patient convenience and compliance. Polyethylene Glycols interferon beta 1 Homo sapiens
4 A 20-kDa polyethylene glycol (PEG)-conjugated IFN beta-1a (PEG-IFN beta-1a) is being developed to decrease the frequency of administration and improve patient convenience and compliance. Polyethylene Glycols interferon beta 1 Homo sapiens